Year |
Citation |
Score |
2023 |
Celada SI, Lim CX, Carisey AF, Ochsner SA, Arce Deza CF, Rexie P, Poli De Frias F, Cardenas-Castillo R, Polverino F, Hengstschläger M, Tsoyi K, McKenna NJ, Kheradmand F, Weichhart T, Rosas IO, ... ... Celada LJ, et al. SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 T cells. Science Translational Medicine. 15: eade2581. PMID 37703351 DOI: 10.1126/scitranslmed.ade2581 |
0.457 |
|
2018 |
Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, et al. PD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production. Science Translational Medicine. 10. PMID 30257954 DOI: 10.1126/Scitranslmed.Aar8356 |
0.446 |
|
2017 |
Hawkins C, Shaginurova G, Shelton DA, Herazo-Maya JD, Oswald-Richter KA, Rotsinger JE, Young A, Celada LJ, Kaminski N, Sevin C, Drake WP. Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis. Journal of Immunology Research. 2017: 3642832. PMID 29234685 DOI: 10.1155/2017/3642832 |
0.464 |
|
2016 |
Celada LJ, Rotsinger JE, Young A, Shaginurova G, Shelton D, Hawkins C, Drake WP. Programmed Death-1 Inhibition of PI3K/AKT/mTOR Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation. American Journal of Respiratory Cell and Molecular Biology. PMID 27564547 DOI: 10.1165/Rcmb.2016-0037Oc |
0.464 |
|
2015 |
Celada LJ, Drake WP. Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy? Immunotherapy. 7: 57-66. PMID 25572480 DOI: 10.2217/Imt.14.103 |
0.404 |
|
2014 |
Cato A, Celada L, Kibakaya EC, Simmons N, Whalen MM. Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells. Cell Biology and Toxicology. 30: 345-360. PMID 25341744 DOI: 10.1007/S10565-014-9289-Y |
0.358 |
|
2014 |
Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM, Grutters J, Culver DA, Dworski R, Sheller J, Massion PP, Polosukhin VV, Johnson JE, Kaminski N, Wilkes DS, et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. American Journal of Respiratory and Critical Care Medicine. 190: 560-71. PMID 25073001 DOI: 10.1164/Rccm.201401-0188Oc |
0.446 |
|
2014 |
Celada LJ, Whalen MM. Effects of butyltins on mitogen-activated-protein kinase kinase kinase and Ras activity in human natural killer cells. Journal of Applied Toxicology : Jat. 34: 1002-11. PMID 24038145 DOI: 10.1002/Jat.2921 |
0.338 |
|
Show low-probability matches. |